Shanghai Jinghai Weixiang Biomedical Materials’ project to produce 1 million tons of lactic acid, lactide, and polylactic acid has been approved for implementation in Huai’an, Jiangsu

Thread Content

On February 11, the project of Shanghai Jinghai Weixiang Biomaterials Co., Ltd. to produce 1 million tons per year of lactic acid, lactide, and polylactic acid was officially signed and established in the Huai’an Industrial Park in Jiangsu Province. Shanghai Jinghai Weixiang Biomaterials Co., Ltd. is a high-tech enterprise of ** level, equipped with cutting-edge synthetic biology technologies and capabilities in the research and development of bio-based materials. The company utilizes cutting-edge next-generation synthetic biology technologies to build super cell factories, achieving full coverage of the entire industrial chain from \"biomass – lactic acid – lactide – PLA – products – rPLA recycling.\" Its products are widely used in fields such as consumer household goods, 3D printing, textile fibers, biomedicine, and automobile manufacturing. The project with an annual production capacity of 1 million tons of lactic acid, lactide, and polylactic acid will be constructed in phases; once all parts of the project are completed and put into operation, it is expected to generate an annual output value of over 10 billion yuan. The project was discussed and evaluated on January 4, and a contract was signed on February 11. It represents another significant achievement in the park’s efforts to advance major industrial projects. It is well aligned with the park’s core industry in chemical new materials, and it will help drive the park’s industries toward higher levels of development and greater sustainability, thereby injecting new momentum into the park’s high-quality growth.